NovaBridge Biosciences NBP
NASDAQ NBP
$1.38 -0.05 (-3.51%)
As of: Oct 21, 2026 · 3:57 PM EDT

NovaBridge Biosciences (NBP) Capital Expenditures (2019 - 2024)

Updated

NovaBridge Biosciences (NBP) reported Capital Expenditures of -$7,000 for FY2025, compared with -$48,000 in FY2024.

Analysis

NovaBridge Biosciences (NBP) Capital Expenditures (2019 - 2024) Analysis & Trends

Dating back to FY2017, NovaBridge Biosciences' Capital Expenditures record includes 9 years.

  • The FY2025 figure ranks as the highest annual Capital Expenditures in data going back to FY2017.
  • According to Business Quant data, Capital Expenditures came in at -$48,000 in FY2024, -$164,000 in FY2023, -$2.09 million in FY2022 and -$4.7 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 NovaBridge Biosciences 131.20 Mn -664.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 38,000.00
Sep 30, 2024 1,000.00
Dec 31, 2020 489,950.53
Sep 30, 2020 707,369.29
Dec 31, 2019 1.08 Mn
API Access

NovaBridge Biosciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NBP&period=max&api_key=YOUR_API_KEY